Modulation of the pharmacological activities of secretory phospholipase A2 from Crotalus durissus cascavella induced by naringin.
In this work we have characterized the action of the naringin, a flavonoid found in grapefruit and known for its various pharmacological effects, which include antioxidant blood lipid lowering and anticancer activity, on the structure and biochemical activities of a secretory phospholipase A (sPLA2) from Crotalus durissus cascavella, an important protein involved in the releasinge of arachidonic acid in phospholipid membranes. sPLA2 was incubated with naringin (mol:mol) at 37 °C and a discrete reduction in the UV scanning signal and a modification of the circular dichroism spectra were observed after treatment with naringin, suggesting modifications of the secondary structure of the protein. This flavonoid was able to decrease enzymatic activity and some pharmacological effects, such as myonecrosis, platelet aggregation, and neurotoxic activity caused by sPLA2, however, the inflammatory effect was not affected by naringin. In addition, small angle X-ray scattering (SAXS) data were collected for sPLA2 and naringin-treated sPLA2 to evaluate possible modifications of the protein structure. These structural investigations have shown that sPLA2 is an elongated dimer in solution and after treatment with naringin a conformational change in the dimeric configuration was observed. Our results suggest that structural modification may be correlated with the loss of enzymatic activity and alterations in pharmacological properties.
Laboratório de Biologia Estrutural e Cristalografia, Instituto de Química, UNICAMP, Campinas, São Paulo, Brazil.
Marcelo L
ML
Santos
Daniela O
DO
Toyama
Simone C B
SC
Oliveira
Camila A
CA
Cotrim
Eduardo B S
EB
Diz-Filho
Fábio H R
FH
Fagundes
Veronica C G
VC
Soares
Ricardo
R
Aparicio
Marcos H
MH
Toyama
D000818:Animals; D017839:Crotalus / Q000378:metabolism*; D044950:Flavanones / Q000494:pharmacology*; D054497:Phospholipases A2, Secretory / Q000037:antagonists & inhibitors*; D051381:Rats; D012542:Scattering, Radiation; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D044950:Flavanones; D054497:Phospholipases A2, Secretory; C005274:naringin
Toxicon. 2005 Dec 1;46(7):736-50
16198388
Toxicon. 2007 Mar 1;49(3):378-87
17157889
Farmaco. 2001 Sep;56(9):683-7
11680812
Toxicon. 1998 Mar;36(3):503-14
9637370
J Agric Food Chem. 2008 Aug 13;56(15):6185-205
18593176
J Struct Biol. 1999 Apr-May;125(2-3):185-95
10222274
Toxicon. 2009 Jan;53(1):104-14
19013478
Acta Crystallogr D Biol Crystallogr. 1995 May 1;51(Pt 3):311-7
15299297
Pharmacol Rev. 2000 Dec;52(4):673-751
11121513
J Mol Biol. 1996 Oct 4;262(4):559-74
8893863
Toxicon. 1996 Aug;34(8):827-41
8875770
Toxicon. 2003 Jun;41(7):823-9
12782082
Biochem Pharmacol. 1997 Mar 7;53(5):733-40
9113093
Toxicon. 2006 Jan;47(1):47-57
16307769
Curr Opin Struct Biol. 2002 Oct;12(5):654-60
12464319
Adv Protein Chem. 1994;45:53-88
8154374
Biochem Pharmacol. 1998 Jan 15;55(2):105-11
9448732
J Mol Biol. 1999 Sep 17;292(2):195-202
10493868
Life Sci. 1999;65(4):337-53
10421421
Bioinformatics. 2000 Apr;16(4):404-5
10869041
Protein J. 2006 Apr;25(3):183-92
16729248
Arch Biochem Biophys. 1999 Jun 15;366(2):177-82
10356281
Toxicon. 2009 Mar 15;53(4):417-26
19470355
Biochemistry. 2006 Nov 7;45(44):13203-18
17073442
Acta Crystallogr D Biol Crystallogr. 1999 Jun;55(Pt 6):1229-30
10329793
Agents Actions. 1988 Dec;25(3-4):394-400
3218613
Mediators Inflamm. 2001 Jun;10(3):125-33
11545249
Q Rev Biophys. 2007 Aug;40(3):191-285
18078545
Toxicon. 2003 Jul;42(1):53-62
12893061
Toxicon. 2003 Jun;41(8):1033-8
12875878
Annu Rev Biochem. 1997;66:549-79
9242917
Toxicon. 2005 Dec 1;46(7):751-8
16185736
Nucleic Acids Res. 2003 Jul 1;31(13):3381-5
12824332
J Mol Biol. 2007 Sep 21;372(3):774-97
17681537
Appl Biochem Biotechnol. 2008 Jul;150(1):97-111
18568300
Proteins. 2008 Aug 15;72(3):883-91
18275084
Biophys J. 2001 Jun;80(6):2946-53
11371467
J Mol Biol. 1987 Feb 20;193(4):775-91
2441069
Acta Crystallogr D Biol Crystallogr. 1999 Dec;55(Pt 12):1986-96
10666574
Acta Crystallogr D Biol Crystallogr. 2003 Feb;59(Pt 2):255-62
12554936
Br J Pharmacol Chemother. 1960 Sep;15:410-1
13705512
J Struct Biol. 2007 May;158(2):214-23
17182256
Pharmacol Res. 2003 Dec;48(6):601-6
14527825
Biochim Biophys Acta. 2008 Jan-Feb;1781(1-2):1-9
18177747
Proteins. 1998 Mar 1;30(4):442-54
9533628
Acta Crystallogr D Biol Crystallogr. 2005 Dec;61(Pt 12):1670-7
16301802
Curr Opin Chem Biol. 2001 Feb;5(1):51-6
11166648
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1897-970
12733525
J Lipid Res. 2009 Apr;50 Suppl:S237-42
19011112
FEBS Lett. 2002 Oct 30;531(1):7-11
12401194
Inflammation. 1988 Dec;12(6):549-61
3220517
Biochem Mol Biol Int. 1995 Dec;37(6):1047-55
8747534
Toxicon. 2000 Dec;38(12):1773-85
10858516
Biophys J. 2005 Aug;89(2):1237-50
15923225
Toxicon. 1998 Nov;36(11):1623-33
9792179
J Appl Crystallogr. 2009 Apr 1;42(Pt 2):342-346
27630371
Int J Mol Sci. 2008 May;9(5):736-750
19325781
Chem Biol Interact. 2002 Jan 22;139(1):1-21
11803026
Inflammation. 1997 Jun;21(3):347-56
9246576
Protein J. 2005 Feb;24(2):103-12
16003952
Protein J. 2005 May;24(4):233-42
16283546